4.5 Article

Crry deficiency in complement sufficient mice: C3 consumption occurs without associated renal injury

期刊

MOLECULAR IMMUNOLOGY
卷 46, 期 5, 页码 803-811

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.molimm.2008.09.003

关键词

Complement; Crry; Knockout; Mouse

资金

  1. Wellcome Trust programme [068590]
  2. Cardiff University
  3. Wellcome Trust project [079115]
  4. MRC New Investigator Award [G0700102]
  5. Wellcome Trust University Award [068823]
  6. Medical Research Council [G0700102] Funding Source: researchfish
  7. MRC [G0700102] Funding Source: UKRI

向作者/读者索取更多资源

The rodent-specific complement regulator complement receptor 1-related gene/protein-y(Crry) is critical for complement homeostasis. Gene deletion is 100% embryonically lethal; Crry-deficient (Crry(-/-)) mice were rescued by back-crossing onto C3 deficiency, confirming that embryo loss was complement mediated. In order to rescue viable Crry(-/-) mice without deleting C3, we have tested inhibition of C5 during gestation. Crry(+/-) females were given neutralizing anti-C5 mAb immediately prior to mating with Crry(+/-) males and C5 inhibition maintained through pregnancy. A single, healthy Crry(-/-) female was obtained and mating with Crry(+/-) males yielded healthy litters containing equal numbers of Crry(+/-) and Crry pups. Inter-crossing Crry (/) mice yielded healthy litters of expected size. Although the mice were not anemic, exposure of Crry(-/-) erythrocytes to normal mouse serum caused C3 deposition and lysis, while transfusion into normal or C6 / mice resulted in rapid clearance. Complement activity and C3 levels in Crry(-/-) mice were markedly reduced. Comparison with factor H deficient (CfH (/)) mice revealed similar levels of residual C3; however, unlike the CfH-/- mice, Crry (/) mice showed no evidence of renal injury, demonstrating distinct roles for these regulators in protecting the kidney. (C) 2008 Published by Elsevier Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据